Skip to content

The epidural analgesic efficiency of different concentrations of ropivacaine combined with sufentanil in patients after caesarean section

The epidural analgesic efficiency of different concentrations of ropivacaine combined with sufentanil in patients after caesarean section

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021740
Enrollment
Unknown
Registered
2019-03-07
Start date
2019-03-01
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia after caesarean section

Interventions

Group A:0.1%ropivacaine
Group B:0.15%ropivacaine
Group C:0.1%ropivacaine and 0.5ug/ml sufentanil
Group D:0.15%ropivacaine and 0.5ug/ml sufentanil

Sponsors

Xuan Wu hospital of CCMU
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
21 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Aged 21-45 years old; 2. >32 weeks of gestation; 3. American Society of Anesthesiologists physical status class I-II; 4. Scheduled to undergo cesarean section under neuraxial anesthesia.

Exclusion criteria

Exclusion criteria: 1. A history of chronic pain; 2. Intake of pain medication; 3. Allergies against local anesthetics and opioids; 4. Additional surgical procedures; 5. Hemodynamic instability; 6. Contraindications for neuraxial anesthesia; 7. Anxiolytic medication; 8. Eclampsia; 9. HELLP syndrome; 10. Current participation in another clinical trial.

Design outcomes

Primary

MeasureTime frame
pain scores at rest;pain scores during mobilization;Pain scores during uterine massage;Global satisfaction scores;

Secondary

MeasureTime frame
The time to first flatus;The time of first ambulation;The time of highest pain;Times of analgesia pump;Supplementary analgesia;Sedation scores;Bromage scale;Left leg activity time;Right leg activity time;Pruritus;Nausea and vomiting;Numbness;Hypotension;Respiratory depression;Other adverse reactions;

Countries

China

Contacts

Public ContactWANG TIAN LONG

Xuanwu Hospital of CCMU

w_tl5595@hotmail.com+86 13910525304

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026